Genomics Market Size, Share & Trends Analysis Report By Application and Technology (Functional Genomics, Pathway Analysis), By Deliverables (Products, Services), By End Use, By Region, And Segment Forecasts, 2020 - 2027

Published: Feb, 2020 | Pages: 120 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc. Significant changes in disease management processes along with advancements in genomics and personalized medicine are expected to propel the market. 

Increasing pool of market innovators such as 23andMe,Oxford Nanopore Technologies, and Veritas Genetics that have launched breakthrough genomic technologies in recent years are also contributing toward market development. 23andMe has expertise in developing direct-to-consumer genomic tests targeted toward disease prognosis and has recently received FDA approval for its commercialization.

MinION - a trademark sequencing device of Oxford Nanopore Technologies, is witnessing significant traction owing to its ability to sequence any fragment length of DNA in real time. On the other hand, Veritas Genetics offers an affordable solution for a complete readout of the genomic sequence. Earlier procured only by doctors, these tests can now be taken by anyone curious about their DNA and costs approximately USD 1,000. The company has also begun the commercialization of this technique for newborn’s genomic sequencing applications in China in 2017.

Further key findings from the report suggest:

• The consumables and reagents deliverable segment is expected to register highest growth rate owing to high costs associated with specific essential reagents along with high volume requirement

• The computational services deliverable segment is set to expand at a considerable CAGR from 2020 - 2027 owing to the increasing demand for computational sequence alignment and analysis among molecular biologists

• Development of predictive biomarkers targeted toward diagnosis and monitoring and substantial investments by biotechnology and pharmaceutical companies have contributed significantly to the revenue generated by the biomarker discovery application segment in 2019

• Asia Pacific is a potentially lucrative market for genomics and is anticipated to expand at the highest CAGR of 9.1%

• Key players of genomics market include 23andMe; F. Hoffmann-La Roche Ltd.; BGI; Myriad Genetics Inc.; Danaher.; Pacific Biosciences; Illumina; Agilent Technologies; Thermo Fisher Scientific, Inc.; Foundation Medicine; Oxford Nanopore Technologies; and Bio-Rad Laboratories.

 Table of Contents

Chapter 1 Research methodology
                 1.1 Market Segmentation & Scope
                 1.2 Market Definition
                 1.3 Information Procurement
                     1.3.1 Purchased database
                     1.3.2 GVR’s internal database
                     1.3.3 Secondary sources & third party perspectives
                     1.3.4 Primary research
                 1.4 Information Analysis
                     1.4.1 Data analysis models
                 1.5 Market Formulation & Data Visualization
                 1.6 Data Validation & Publishing

Chapter 2 Executive Summary
                 2.1 Genomics Market Outlook, 2016 - 2027

Chapter 3 Industry Outlook
                 3.1 Penetration & Growth Prospects Mapping
                 3.2 Trend Analysis
                     3.2.1 Application trends
                     3.2.2 Product trends
                     3.2.3 End-use trends
                     3.2.4 Regional trends
                 3.3 Genomics - Market Dynamics
                     3.3.1 Market driver analysis
                          3.3.1.1 Growing integration of genomics data into clinical workflows
                               3.3.1.1.1 More targeted and personalized healthcare
                               3.3.1.1.2 Growth of newborn genetic screening programs
                               3.3.1.1.3 Advancements in noninvasive cancer screening
                               3.3.1.1.4 Military genomics
                          3.3.1.2 Technological advances to facilitate genomic R&D
                               3.3.1.2.1 Emergence of advanced genome editing techniques
                               3.3.1.2.2 Integration of new data streams
                               3.3.1.2.3 RNA biology
                               3.3.1.2.4 Single cell biology
                          3.3.1.3 Rising adoption of direct to consumer genomics
                          3.3.1.4 Success of genetic tools in agrigenomics
                          3.3.1.5 Increasing participation of different companies
                          3.3.1.6 Increase in government role and funding in genomics
                     3.3.2 Market restraint analysis
                          3.3.2.1 Issues regarding intellectual property protection, data management, and public policies
                          3.3.2.2 Dearth of skilled personnel
                 3.4 Oppurtunity Analysis
                 3.5 Industry Analysis - Porter's
                     3.5.1 Supplier power - Medium
                     3.5.2 Buyer power - High
                     3.5.3 Substitution threat - Low
                     3.5.4 New entrants threat - Low
                 3.6 Regulatory Landscape: Genomics– SWOT by PEST Analysis
                     3.6.1 Political landscape
                     3.6.2 Economic landscape
                     3.6.3 Social landscape
                     3.6.4 Technology landscape
                 3.7 Company Market Share Analysis
                 3.8 Competitive Landscape
                     3.8.1 Strategy framework
                     3.8.2 Company categorization
                          3.8.2.1 New entrants
                          3.8.2.2 Mature players & leaders

Chapter 4 Genomics Market Categorization: Deliverable Outlook
                 4.1 Genomics Market Share By Deliverable Outlook, 2016 to 2027
                 4.2 Products Market, 2016 to 2027
                     4.2.1 Products market revenue (USD Million), by North America
                     4.2.2 Products market revenue (USD Million), by Europe
                     4.2.3 Products market revenue (USD Million), by Asia Pacific
                     4.2.4 Products market revenue (USD Million), by Latin America
                     4.2.5 Products market revenue (USD Million), by Middle-East & Africa
                     4.2.6 Instruments & software market, 2016 to 2027 USD Million
                          4.2.6.1 Instruments & software market revenue (USD Million), by North America
                          4.2.6.2 Instruments & software market revenue (USD Million), by Europe
                          4.2.6.3 Instruments & software market revenue (USD Million), by Asia Pacific
                          4.2.6.4 Instruments & software market revenue (USD Million), by Latin America
                          4.2.6.5 Instruments & software market revenue (USD Million), by Middle-East & Africa
                     4.2.7 Consumables & Reagents, 2016 to 2027 USD Million
                          4.2.7.1 Consumables & Reagents market revenue (USD Million), by North America
                          4.2.7.2 Consumables & Reagents market revenue (USD Million), by Europe
                          4.2.7.3 Consumables & Reagents market revenue (USD Million), by Asia Pacific
                          4.2.7.4 Consumables & Reagents market revenue (USD Million), by Latin America
                          4.2.7.5 Consumables & Reagents market revenue (USD Million), by Middle-East & Africa
                 4.3 Services Market, 2016 to 2027
                     4.3.1 Services market revenue (USD Million), by North America
                     4.3.2 Services market revenue (USD Million), by Europe
                     4.3.3 Services market revenue (USD Million), by Asia Pacific
                     4.3.4 Services market revenue (USD Million), by Latin America
                     4.3.5 Services market revenue (USD Million), by Middle-East & Africa
                     4.3.6 Core genomic services, 2016 to 2027
                          4.2.6.1 Core genomic services market revenue (USD Million), by North America
                          4.2.6.2 Core genomic services market revenue (USD Million), by Europe
                          4.2.6.3 Core genomic services market revenue (USD Million), by Asia Pacific
                          4.2.6.4 Core genomic services market revenue (USD Million), by Latin America
                          4.2.6.5 Core genomic services market revenue (USD Million), by Middle-East & Africa
                     4.3.7 NGS-based services, 2016 to 2027
                          4.2.7.1 NGS-based services market revenue (USD Million), by North America
                          4.2.7.2 NGS-based services market revenue (USD Million), by Europe
                          4.2.7.3 NGS-based services market revenue (USD Million), by Asia Pacific
                          4.2.7.4 NGS-based services market revenue (USD Million), by Latin America
                          4.2.7.5 NGS-based services market revenue (USD Million), by Middle-East & Africa
                     4.3.8 Biomarker translation services, 2016 to 2027
                          4.2.8.1 Biomarker translation services market revenue (USD Million), by North America
                          4.2.8.2 Biomarker translation services market revenue (USD Million), by Europe
                          4.2.8.3 Biomarker translation services market revenue (USD Million), by Asia Pacific
                          4.2.8.4 Biomarker translation services market revenue (USD Million), by Latin America
                          4.2.8.5 Biomarker translation services market revenue (USD Million), by Middle-East & Africa
                     4.3.9 Computational services, 2016 to 2027
                          4.2.9.1 Computational services market revenue (USD Million), by North America
                          4.2.9.2 Computational services market revenue (USD Million), by Europe
                          4.2.9.3 Computational services market revenue (USD Million), by Asia Pacific
                          4.2.9.4 Computational services market revenue (USD Million), by Latin America
                          4.2.9.5 Computational services market revenue (USD Million), by Middle-East & Africa
                     4.3.10 Other services, 2016 to 2027
                          4.2.10.1 Other services market revenue (USD Million), by North America
                          4.2.10.2 Other services market revenue (USD Million), by Europe
                          4.2.10.3 Other services market revenue (USD Million), by Asia Pacific
                          4.2.10.4 Other services market revenue (USD Million), by Latin America
                          4.2.10.5 Other services market revenue (USD Million), by Middle-East & Africa

Chapter 5 Genomics Market Categorization: Application & Technology Outlook
                 5.1 Genomics Market Share By Application Outlook, 2016 to 2027
                 5.2 Functional Genomics, 2016 to 2027
                     5.2.1 Functional genomics market revenue (USD Million), by North America
                     5.2.2 Functional genomics market revenue (USD Million), by Europe
                     5.2.3 Functional genomics market revenue (USD Million), by Asia Pacific
                     5.2.4 Functional genomics market revenue (USD Million), by Latin America
                     5.2.5 Functional genomics market revenue (USD Million), by Middle-East & Africa
                     5.2.6 Transfection, 2016 to 2027
                          5.2.6.1 Transfection market revenue (USD Million), by North America
                          5.2.6.2 Transfection market revenue (USD Million), by Europe
                          5.2.6.3 Transfection market revenue (USD Million), by Asia Pacific
                          5.2.6.4 Transfection market revenue (USD Million), by Latin America
                          5.2.6.5 Transfection market revenue (USD Million), by Middle-East & Africa
                     5.2.7 Real time PCR, 2016 to 2027
                          5.2.7.1 Real time PCR market revenue (USD Million), by North America
                          5.2.7.2 Real time PCR market revenue (USD Million), by Europe
                          5.2.7.3 Real time PCR market revenue (USD Million), by Asia Pacific
                          5.2.7.4 Real time PCR market revenue (USD Million), by Latin America
                          5.2.7.5 Real time PCR market revenue (USD Million), by Middle-East & Africa
                     5.2.8 RNA interference, 2016 to 2027
                          5.2.8.1 RNA interference market revenue (USD Million), by North America
                          5.2.8.2 RNA interference market revenue (USD Million), by Europe
                          5.2.8.3 RNA interference market revenue (USD Million), by Asia Pacific
                          5.2.8.4 RNA interference market revenue (USD Million), by Latin America
                          5.2.8.5 RNA interference market revenue (USD Million), by Middle-East & Africa
                     5.2.9 Mutational analysis, 2016 to 2027
                          5.2.9.1 Mutational analysis market revenue (USD Million), by North America
                          5.2.9.2 Mutational analysis market revenue (USD Million), by Europe
                          5.2.9.3 Mutational analysis market revenue (USD Million), by Asia Pacific
                          5.2.9.4 Mutational analysis market revenue (USD Million), by Latin America
                          5.2.9.5 Mutational analysis market revenue (USD Million), by Middle-East & Africa
                          5.2.10 SNP analysis, 2016 to 2027
                          5.2.10.1 SNP analysis market revenue (USD Million), by North America
                          5.2.10.2 SNP analysis market revenue (USD Million), by Europe
                          5.2.10.3 SNP analysis market revenue (USD Million), by Asia Pacific
                          5.2.10.4 SNP analysis market revenue (USD Million), by Latin America
                          5.2.10.5 SNP analysis market revenue (USD Million), by Middle-East & Africa
                     5.2.11 Microarray analysis, 2016 to 2027
                          5.2.11.1 Microarray analysis market revenue (USD Million), by North America
                          5.2.11.2 Microarray analysis market revenue (USD Million), by Europe
                          5.2.11.3 Microarray analysis market revenue (USD Million), by Asia Pacific
                          5.2.11.4 Microarray analysis market revenue (USD Million), by Latin America
                          5.2.11.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
                 5.3 Epigenetics, 2016 to 2027
                     5.3.1 Epigenetics market revenue (USD Million), by North America
                     5.3.2 Epigenetics market revenue (USD Million), by Europe
                     5.3.3 Epigenetics market revenue (USD Million), by Asia Pacific
                     5.3.4 Epigenetics market revenue (USD Million), by Latin America
                     5.3.5 Epigenetics market revenue (USD Million), by Middle-East & Africa
                     5.3.6 Bisulfite sequencing, 2016 to 2027
                          5.3.6.1 Bisulfite sequencing market revenue (USD Million), by North America
                          5.3.6.2 Bisulfite sequencing market revenue (USD Million), by Europe
                          5.3.6.3 Bisulfite sequencing market revenue (USD Million), by Asia Pacific
                          5.3.6.4 Bisulfite sequencing market revenue (USD Million), by Latin America
                          5.3.6.5 Bisulfite sequencing market revenue (USD Million), by Middle-East & Africa
                     5.3.7 Chromatin immunoprecipitation-sequencing (ChIP-Seq), 2016 to 2027
                          5.3.7.1 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by North America
                          5.3.7.2 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Europe
                          5.3.7.3 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Asia Pacific
                          5.3.7.4 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Latin America
                          5.3.7.5 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue (USD Million), by Middle-East & Africa
                     5.3.8 Methylated DNA immunoprecipitation (MeDIP), 2016 to 2027
                          5.3.8.1 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by North America
                          5.3.8.2 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Europe
                          5.3.8.3 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Asia Pacific
                          5.3.8.4 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Latin America
                          5.3.8.5 Methylated DNA immunoprecipitation (MeDIP) market revenue (USD Million), by Middle-East & Africa
                     5.3.9 High resolution melt, 2016 to 2027
                          5.3.9.1 High resolution melt market revenue (USD Million), by North America
                          5.3.9.2 High resolution melt market revenue (USD Million), by Europe
                          5.3.9.3 High resolution melt market revenue (USD Million), by Asia Pacific
                          5.3.9.4 High resolution melt market revenue (USD Million), by Latin America
                          5.3.9.5 High resolution melt market revenue (USD Million), by Middle-East & Africa
                     5.3.10 Chromatin accessibility assays, 2016 to 2027
                          5.3.10.1 Chromatin accessibility assays market revenue (USD Million), by North America
                          5.3.10.2 Chromatin accessibility assays market revenue (USD Million), by Europe
                          5.3.10.3 Chromatin accessibility assays market revenue (USD Million), by Asia Pacific
                          5.3.10.4 Chromatin accessibility assays market revenue (USD Million), by Latin America
                          5.3.10.5 Chromatin accessibility assays market revenue (USD Million), by Middle-East & Africa
                     5.3.11 Microarray analysis, 2016 to 2027
                          5.3.11.1 Microarray analysis market revenue (USD Million), by North America
                          5.3.11.2 Microarray analysis market revenue (USD Million), by Europe
                          5.3.11.3 Microarray analysis market revenue (USD Million), by Asia Pacific
                          5.3.11.4 Microarray analysis market revenue (USD Million), by Latin America
                          5.3.11.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
                 5.4 Pathway Analysis, 2016 to 2027
                     5.4.1 Pathway analysis market revenue (USD Million), by North America
                     5.4.2 Pathway analysis market revenue (USD Million), by Europe
                     5.4.3 Pathway analysis market revenue (USD Million), by Asia Pacific
                     5.4.4 Pathway analysis market revenue (USD Million), by Latin America
                     5.4.5 Pathway analysis market revenue (USD Million), by Middle-East & Africa
                     5.4.6 Bead-based analysis (Bio-Plex), 2016 to 2027
                          5.4.6.1 Bead-based analysis (Bio-Plex) market revenue (USD Million), by North America
                          5.4.6.2 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Europe
                          5.4.6.3 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Asia Pacific
                          5.4.6.4 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Latin America
                          5.4.6.5 Bead-based analysis (Bio-Plex) market revenue (USD Million), by Middle-East & Africa
                     5.4.7 Microarray analysis, 2016 to 2027
                          5.4.7.1 Microarray analysis market revenue (USD Million), by North America
                          5.4.7.2 Microarray analysis market revenue (USD Million), by Europe
                          5.4.7.3 Microarray analysis market revenue (USD Million), by Asia Pacific
                          5.4.7.4 Microarray analysis market revenue (USD Million), by Latin America
                          5.4.7.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
                     5.4.8 Real time PCR, 2016 to 2027
                          5.4.8.1 Real time PCR market revenue (USD Million), by North America
                          5.4.8.2 Real time PCR market revenue (USD Million), by Europe
                          5.4.8.3 Real time PCR market revenue (USD Million), by Asia Pacific
                          5.4.8.4 Real time PCR market revenue (USD Million), by Latin America
                          5.4.8.5 Real time PCR market revenue (USD Million), by Middle-East & Africa
                     5.4.9 Proteomics tools (2-D PAGE; yeast 2-hybrid studies), 2016 to 2027
                          5.4.9.1 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by North America
                          5.4.9.2 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Europe
                          5.4.9.3 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Asia Pacific
                          5.4.9.4 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Latin America
                          5.4.9.5 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue (USD Million), by Middle-East & Africa
                 5.5 Biomarker Discovery, 2016 to 2027
                     5.5.1 Biomarker Discovery market revenue (USD Million), by North America
                     5.5.2 Biomarker Discovery market revenue (USD Million), by Europe
                     5.5.3 Biomarker Discovery market revenue (USD Million), by Asia Pacific
                     5.5.4 Biomarker Discovery market revenue (USD Million), by Latin America
                     5.5.5 Biomarker Discovery market revenue (USD Million), by Middle-East & Africa
                     5.5.6 Mass spectrometry, 2016 to 2027
                          5.5.6.1 Mass spectrometry market revenue (USD Million), by North America
                          5.5.6.2 Mass spectrometry market revenue (USD Million), by Europe
                          5.5.6.3 Mass spectrometry market revenue (USD Million), by Asia Pacific
                          5.5.6.4 Mass spectrometry market revenue (USD Million), by Latin America
                          5.5.6.5 Mass spectrometry market revenue (USD Million), by Middle-East & Africa
                     5.5.7 Real time PCR, 2016 to 2027
                          5.5.7.1 Real time PCR market revenue (USD Million), by North America
                          5.5.7.2 Real time PCR market revenue (USD Million), by Europe
                          5.5.7.3 Real time PCR market revenue (USD Million), by Asia Pacific
                          5.5.7.4 Real time PCR market revenue (USD Million), by Latin America
                          5.5.7.5 Real time PCR market revenue (USD Million), by Middle-East & Africa
                     5.5.8 Microarray analysis, 2016 to 2027
                          5.5.8.1 Microarray analysis market revenue (USD Million), by North America
                          5.5.8.2 Microarray analysis market revenue (USD Million), by Europe
                          5.5.8.3 Microarray analysis market revenue (USD Million), by Asia Pacific
                          5.5.8.4 Microarray analysis market revenue (USD Million), by Latin America
                          5.2.8.5 Microarray analysis market revenue (USD Million), by Middle-East & Africa
                     5.5.9 Statistical analysis, 2016 to 2027
                          5.5.9.1 Statistical analysis market revenue (USD Million), by North America
                          5.5.9.2 Statistical analysis market revenue (USD Million), by Europe
                          5.5.9.3 Statistical analysis market revenue (USD Million), by Asia Pacific
                          5.5.9.4 Statistical analysis market revenue (USD Million), by Latin America
                          5.5.9.5 Statistical analysis market revenue (USD Million), by Middle-East & Africa
                     5.5.10 Bioinformatics, 2016 to 2027
                          5.5.10.1 Bioinformatics market revenue (USD Million), by North America
                          5.5.10.2 Bioinformatics market revenue (USD Million), by Europe
                          5.5.10.3 Bioinformatics market revenue (USD Million), by Asia Pacific
                          5.5.10.4 Bioinformatics market revenue (USD Million), by Latin America
                          5.5.10.5 Bioinformatics market revenue (USD Million), by Middle-East & Africa
                     5.5.11 DNA sequencing, 2016 to 2027
                          5.5.11.1 DNA sequencing market revenue (USD Million), by North America
                          5.5.11.2 DNA sequencing market revenue (USD Million), by Europe
                          5.5.11.3 DNA sequencing market revenue (USD Million), by Asia Pacific
                          5.5.11.4 DNA sequencing market revenue (USD Million), by Latin America
                          5.5.11.5 DNA sequencing market revenue (USD Million), by Middle-East & Africa
                 5.6 Others, 2016 to 2027
                     5.6.1 Others market revenue (USD Million), by North America
                     5.6.2 Others market revenue (USD Million), by Europe
                     5.6.3 Others market revenue (USD Million), by Asia Pacific
                     5.6.4 Others market revenue (USD Million), by Latin America
                     5.6.5 Others market revenue (USD Million), by Middle-East & Africa

Chapter 6 Genomics Market Categorization: End-use Outlook
                 6.1 Genomics Market Share by End-use, 2016 to 2027
                 6.2 Clinical & Research Laboratories, 2016 to 2027
                     6.2.1 Clinical & research laboratories market revenue (USD Million), by North America
                     6.2.2 Clinical & research laboratories market revenue (USD Million), by Europe
                     6.2.3 Clinical & research laboratories market revenue (USD Million), by Asia Pacific
                     6.2.4 Clinical & research laboratories market revenue (USD Million), by Latin America
                     6.2.5 Clinical & research laboratories market revenue (USD Million), by Middle-East & Africa
                 6.3 Academic and Government Institutes, 2016 to 2027
                     6.3.1 Academic & government institutes market revenue (USD Million), by North America
                     6.3.2 Academic & government institutes market revenue (USD Million), by Europe
                     6.3.3 Academic & government institutes market revenue (USD Million), by Asia Pacific
                     6.3.4 Academic & government institutes market revenue (USD Million), by Latin America
                     6.3.5 Academic & government institutes market revenue (USD Million), by Middle-East & Africa
                 6.4 Hospitals and Clinics, 2016 to 2027
                     6.4.1 Hospitals & clinics market revenue (USD Million), by North America
                     6.4.2 Hospitals & clinics market revenue (USD Million), by Europe
                     6.4.3 Hospitals & clinics market revenue (USD Million), by Asia Pacific
                     6.4.4 Hospitals & clinics market revenue (USD Million), by Latin America
                     6.4.5 Hospitals & clinics market revenue (USD Million), by Middle-East & Africa
                 6.5 Pharmaceutical and Biotechnology Companies, 2016 to 2027
                     6.5.1 Pharmaceutical & biotechnology companies market revenue (USD Million), by North America
                     6.5.2 Pharmaceutical & biotechnology companies market revenue (USD Million), by Europe
                     6.5.3 Pharmaceutical & biotechnology companies market revenue (USD Million), by Asia Pacific
                     6.5.4 Pharmaceutical & biotechnology companies market revenue (USD Million), by Latin America
                     6.5.5 Pharmaceutical & biotechnology companies market revenue (USD Million), by Middle-East & Africa
                 6.6 Other End Users, 2016 to 2027
                     6.6.1 Other end users market revenue (USD Million), by North America
                     6.6.2 Other end users market revenue (USD Million), by Europe
                     6.6.3 Other end users market revenue (USD Million), by Asia Pacific
                     6.6.4 Other end users market revenue (USD Million), by Latin America
                     6.6.5 Other end users market revenue (USD Million), by Middle-East & Africa

Chapter 7 Genomics Market Categorization: Regional Outlook
                 7.1 Genomics Market Share By Region, 2016 to 2027
                 7.2 North America
                     7.2.1 Genomics market revenue, (USD Million), by U.S.
                     7.2.2 Genomics market revenue, (USD Million), by Canada
                     7.2.3 U.S.
                          7.2.3.1 Genomics market, by deliverable
                          7.2.3.2 Genomics market, by application & technology
                          7.2.3.3 Genomics market, by end use
                     7.2.4 Canada
                          7.2.4.1 Genomics market, by deliverable
                          7.2.4.2 Genomics market, by application & technology
                          7.2.4.3 Genomics market, by end use
                 7.3 Europe
                     7.3.1 Genomics market revenue, (USD Million), by Germany
                     7.3.2 Genomics market revenue, (USD Million), by U.K.
                     7.3.3 Germany
                          7.3.3.1 Genomics market, by deliverable
                          7.3.3.2 Genomics market, by application & technology
                          7.3.3.3 Genomics market, by end use
                     7.3.4 U.K.
                          7.3.4.1 Genomics market, by deliverable
                          7.3.4.2 Genomics market, by application & technology
                          7.3.4.3 Genomics market, by end use
                 7.4 Asia Pacific
                     7.4.1 Genomics market revenue, (USD Million), by Japan
                     7.4.2 Genomics market revenue, (USD Million), by China
                     7.4.3 Japan
                          7.4.3.1 Genomics market, by deliverable
                          7.4.3.2 Genomics market, by application & technology
                          7.4.3.3 Genomics market, by end use
                     7.4.4 China
                          7.4.4.1 Genomics market, by deliverable
                          7.4.4.2 Genomics market, by application & technology
                          7.4.4.3 Genomics market, by end use
                 7.5 Latin America
                     7.5.1 Genomics market revenue, (USD Million), by Brazil
                     7.5.2 Brazil
                          7.5.2.1 Genomics market, by deliverable
                          7.5.2.2 Genomics market, by application & technology
                          7.5.2.3 Genomics market, by end use
                 7.6 MEA
                     7.6.1 Genomics market revenue, (USD Million), by South Africa
                     7.6.2 South Africa
                          7.6.2.1 Genomics market, by deliverable
                          7.6.2.2 Genomics market, by application & technology
                          7.6.2.3 Genomics market, by end use

Chapter 8 Company Profiles
                 8.1 Company Profiles
                     8.1.1 Thermo Fisher Scientific, Inc.
                          8.1.1.1 Company overview
                              8.1.1.1.1 Life Technologies Corp.
                              8.1.1.1.2 Affymetrix, Inc.
                              8.1.1.1.3 Applied Biosystems
                          8.1.1.2 Financial performance
                              8.1.1.2.1 Financial performance (Affymetrix)
                          8.1.1.3 Product benchmarking
                          8.1.1.4 Strategic initiatives
                     8.1.2 Agilent Technologies
                          8.1.2.1 Company overview
                          8.1.2.2 Financial performance
                          8.1.2.3 Product benchmarking
                          8.1.2.4 Strategic initiatives
                     8.1.3 BGI
                          8.1.3.1 Company overview
                              8.1.3.1.1 Complete Genomics Incorporated
                          8.1.3.2 Financial performance
                          8.1.3.3 Product benchmarking
                          8.1.3.4 Strategic initiatives
                     8.1.4 Bio-Rad Laboratories, Inc.
                          8.1.4.1 Company overview
                              8.1.4.1.1 GnuBIO
                          8.1.4.2 Financial performance
                          8.1.4.3 Product benchmarking
                          8.1.4.4 Strategic initiatives
                     8.1.5 Danaher
                          8.1.5.1 Company overview
                              8.1.5.1.1 Beckman Coulter, Inc.
                              8.1.5.1.2 Cepheid
                          8.1.5.2 Financial performance
                          8.1.5.3 Product benchmarking
                          8.1.5.4 Strategic initiatives
                     8.1.6 F. Hoffmann-La Roche Ltd.
                          8.1.6.1 Company overview
                              8.1.6.1.1 454 Life Sciences (Roche Diagnostics Corporation)
                              8.1.6.1.2 Genentech, Inc.
                              8.1.6.1.3 Ventana Medical Systems, Inc.
                          8.1.6.2 Financial performance
                              8.1.6.2.1 Financial performance
                          8.1.6.3 Product benchmarking
                          8.1.6.4 Strategic initiatives
                     8.1.7 GE Healthcare
                          8.1.7.1 Company overview
                          8.1.7.2 Financial performance
                          8.1.7.3 Product benchmarking
                          8.1.7.4 Strategic initiatives
                     8.1.8 Illumina, Inc.
                          8.1.8.1 Company overview
                          8.1.8.2 Financial performance
                          8.1.8.3 Product benchmarking
                          8.1.8.4 Strategic initiatives
                     8.1.9 Oxford Nanopore Technologies
                          8.1.9.1 Company overview
                          8.1.9.2 Financial performance
                          8.1.9.3 Product benchmarking
                          8.1.9.4 Strategic initiatives
                     8.1.10 Pacific Biosciences of California, Inc.
                          8.1.10.1 Company overview
                          8.1.10.2 Financial performance
                          8.1.10.3 Product benchmarking
                          8.1.10.4 Strategic initiatives
                     8.1.11 QIAGEN
                          8.1.11.1 Company overview
                          8.1.11.2 Financial performance
                          8.1.11.3 Product benchmarking
                          8.1.11.4 Strategic initiatives
                     8.1.12 Quest Diagnostics Incorporated
                          8.1.12.1 Company overview
                          8.1.12.2 Financial performance
                          8.1.12.3 Product benchmarking
                          8.1.12.4 Strategic initiatives
                     8.1.13 Foundation Medicine, Inc.
                          8.1.13.1 Company overview
                          8.1.13.2 Financial performance
                          8.1.13.3 Product benchmarking
                          8.1.13.4 Strategic initiatives
                     8.1.14 Myriad Genetics, Inc.
                          8.1.14.1 Company overview
                          8.1.14.2 Financial performance
                          8.1.14.3 Product benchmarking
                          8.1.14.4 Strategic initiatives
                     8.1.15 Eppendorf AG
                          8.1.15.1 Company overview
                          8.1.15.2 Financial performance
                          8.1.15.3 Product benchmarking
                     8.1.16 Eurofins Scientific
                          8.1.16.1 Company overview
                          8.1.16.2 Financial performance
                          8.1.16.3 Product benchmarking
                          8.1.16.4 Strategic initiatives
                     8.1.17 Color Genomics, Inc.
                          8.1.17.1 Company overview
                          8.1.17.2 Financial performance
                          8.1.17.3 Product benchmarking
                          8.1.17.4 Strategic initiatives
                     8.1.18 23andMe, Inc.
                          8.1.18.1 Company overview
                          8.1.18.2 Financial performance
                          8.1.18.3 Product benchmarking
                          8.1.18.4 Strategic initiatives

List of Tables

TABLE 1 Gene discoveries and its application in personalized treatment for neurologic diseases
TABLE 2 North America genomics market estimates & forecasts, by deliverable, 2016 - 2027 (USD Million)
TABLE 3 North America genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 4 North America genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 5 North America genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 6 North America functional genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 7 North America epigenetics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 8 North America pathway analysis market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 9 North America biomarker discovery market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 10 U.S. genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 11 U.S. genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 12 U.S. genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 13 U.S. genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 14 U.S. functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 15 U.S. epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 16 U.S. pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 17 U.S. biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 18 Canada genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 19 Canada genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 20 Canada genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 21 Canada genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 22 Canada functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 23 Canada epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 24 Canada pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 25 Canada biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 26 Europe genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 27 Europe genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 28 Europe genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 29 Europe genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 30 Europe functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 31 Europe epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 32 Europe pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 33 Europe biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 34 Germany genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 35 Germany genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 36 Germany genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 37 Germany genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 38 Germany functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 39 Germany epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 40 Germany pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 41 Germany biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 42 U.K. genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 43 U.K. genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 44 U.K. genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 45 U.K. genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 46 U.K. functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 47 U.K. epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 48 U.K. pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 49 U.K. biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 50 Asia Pacific genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 51 Asia Pacific genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 52 Asia Pacific genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 53 Asia Pacific genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 54 Asia Pacific functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 55 Asia Pacific epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 56 Asia Pacific pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 57 Asia Pacific biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 58 Japan genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 59 Japan genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 60 Japan genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 61 Japan genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 62 Japan functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 63 Japan epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 64 Japan pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 65 Japan biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 66 China genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 67 China genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 68 China genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 69 China genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 70 China functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 71 China epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 72 China pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 73 China biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 74 Latin America genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 75 Latin America genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 76 Latin America genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 77 Latin America genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 78 Latin America functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 79 Latin America epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 80 Latin America pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 81 Latin America biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 82 Brazil genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 83 Brazil genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 84 Brazil genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 85 Brazil genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 86 Brazil functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 87 Brazil epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 88 Brazil pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 89 Brazil biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 90 MEA genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 91 MEA genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 92 MEA genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 93 MEA genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 94 MEA functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 95 MEA epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 96 MEA pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 97 MEA biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 98 South Africa genomics market estimates & forecasts, by products & services, 2016 - 2027 (USD Million)
TABLE 99 South Africa genomics market estimates & forecasts, by products, 2016 - 2027 (USD Million)
TABLE 100 South Africa genomics services market estimates & forecasts, 2016 - 2027 (USD Million)
TABLE 101 South Africa genomics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 102 South Africa functional genomics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 103 South Africa epigenetics market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 104 South Africa pathway analysis market estimates & forecasts, by technology, 2016 - 2027 (USD Million)
TABLE 105 South Africa biomarker discovery market estimates & forecasts, by technology, 2016 - 2027 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Application of human genome to personal healthcare
FIG. 12 Spinal muscular atrophy (SMA) prenatal screening trend in the department of defence from 2016 to July 2017
FIG. 13 Categories of tests offered by Direct-To-Consumer (DTC) companies
FIG. 14 Global impact of biotech crop adoption in 2019
FIG. 15 Market restraint relevance analysis (Current & future impact)
FIG. 16 Penetration & growth prospect mapping for Technology, 2019
FIG. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 18 Porter’s Five Forces Analysis
FIG. 19 Genomics market: Product outlook key takeaways
FIG. 20 Global genomics market: Deliverable movement analysis
FIG. 21 Global genomics instruments & software market, 2016 - 2027 (USD Million)
FIG. 22 Global genomics consumables & reagents market, 2016 - 2027 (USD Million)
FIG. 23 Global genomics services market, 2016 - 2027 (USD Million)
FIG. 24 Global core genomics services market, 2016 - 2027 (USD Million)
FIG. 25 Global NGS based services market, 2016 - 2027 (USD Million)
FIG. 26 Global biomarker translation services market, 2016 - 2027 (USD Million)
FIG. 27 Global computational services market, 2016 - 2027 (USD Million)
FIG. 28 Global other services market, 2016 - 2027 (USD Million)
FIG. 29 Genomics market: Application outlook key takeaways
FIG. 30 Global genomics market: Application movement analysis
FIG. 31 Global functional genomics market, 2016 - 2027 (USD Million)
FIG. 32 Global transfection in functional genomics market, 2016 - 2027 (USD Million)
FIG. 33 Global real time PCR in functional genomics market, 2016 - 2027 (USD Million)
FIG. 34 Global RNA interference in functional genomics market, 2016 - 2027 (USD Million)
FIG. 35 Global mutational analysis in functional genomics market, 2016 - 2027 (USD Million)
FIG. 36 Global SNP analysis in functional genomics market, 2016 - 2027 (USD Million)
FIG. 37 Global microarray analysis in functional genomics market, 2016 - 2027 (USD Million)
FIG. 38 Global epigenetics market, 2016 - 2027 (USD Million)
FIG. 39 Global bisulfite sequencing in epigenetics market, 2016 - 2027 (USD Million)
FIG. 40 Global chromatin immunoprecipitation-sequencing in epigenetics market, 2016 - 2027 (USD Million)
FIG. 41 Global methylated DNA immunoprecipitation in epigenetics market, 2016 - 2027 (USD Million)
FIG. 42 Global high resolution melt in epigenetics market, 2016 - 2027 (USD Million)
FIG. 43 Global chromatin accessibility assays in epigenetics market, 2016 - 2027 (USD Million)
FIG. 44 Global microarray analysis in epigenetics market, 2016 - 2027 (USD Million)
FIG. 45 Global pathway analysis market, 2016 - 2027 (USD Million)
FIG. 46 Global luminex bead-based analysis (Bio-Plex) for pathway analysis market, 2016 - 2027 (USD Million)
FIG. 47 Global microarray analysis in pathway analysis market, 2016 - 2027 (USD Million)
FIG. 48 Global real time PCR in pathway analysis market, 2016 - 2027 (USD Million)
FIG. 49 Global proteomics tools (2-D PAGE; yeast 2-hybrid studies) in pathway analysis market, 2016 - 2027 (USD Million)
FIG. 50 Global biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 51 Global mass spectrometry for biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 52 Global real time PCR for biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 53 Global microarray analysis for biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 54 Global statistical analysis for biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 55 Global bioinformatics for biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 56 Global DNA sequencing for biomarker discovery market, 2016 - 2027 (USD Million)
FIG. 57 Global other services market, 2016 - 2027 (USD Million)
FIG. 58 Genomics market: End-use outlook key takeaways
FIG. 59 Global genomics market: End-use movement analysis
FIG. 60 Global clinical & research laboratories market, 2016 - 2027 (USD Million)
FIG. 61 Global academic and government institutes market, 2016 - 2027 (USD Million)
FIG. 62 Global hospital and clinics market, 2016 - 2027 (USD Million)
FIG. 63 Global pharmaceutical and biotechnology companies market, 2016 - 2027 (USD Million)
FIG. 64 Global other end users market, 2016 - 2027 (USD Million)
FIG. 65 Regional market place: Key takeaway
FIG. 66 Genomics regional outlook, 2019 & 2027
FIG. 67 North America genomics market, 2016 - 2027 (USD Million)
FIG. 68 U.S. genomics market, 2016 - 2027 (USD Million)
FIG. 69 Canada genomics market, 2016 - 2027 (USD Million)
FIG. 70 Europe genomics market, 2016 - 2027 (USD Million)
FIG. 71 Germany genomics market, 2016 - 2027 (USD Million)
FIG. 72 U.K. genomics market, 2016 - 2027 (USD Million)
FIG. 73 Asia Pacific genomics market, 2016 - 2027 (USD Million)
FIG. 74 Japan genomics market, 2016 - 2027 (USD Million)
FIG. 75 China genomics market, 2016 - 2027 (USD Million)
FIG. 76 Latin America genomics market, 2016 - 2027 (USD Million)
FIG. 77 Brazil genomics market, 2016 - 2027 (USD Million)
FIG. 78 MEA genomics market, 2016 - 2027 (USD Million)
FIG. 79 South Africa genomics market, 2016 - 2027 (USD Million)
FIG. 80 Strategy framework
FIG. 81 Participant categorization